Literature DB >> 2994489

Absence of albumin receptor on brain capillaries in vivo or in vitro.

W M Pardridge, J Eisenberg, W T Cefalu.   

Abstract

Hormones and drugs are known to be available for transport into brain and liver in vivo from the circulating albumin-bound pool. An albumin receptor-mediated mechanism is one possible way in which the transport of ligands from the circulating albumin-bound pool into the tissue may be catalyzed. The albumin receptor model was tested for brain in the present studies using both 125I-albumin (labeled by lactoperoxidase) and [3H]albumin (labeled by reductive methylation). The interaction of the labeled albumin with brain capillaries was assessed in vivo with the carotid injection technique in rats and in vitro with isolated bovine brain capillaries. Artifactually high nonspecific binding in both the in vivo and in vitro assays was observed with 125I-albumin. Conversely, the transit time of [3H]albumin through the brain capillaries in vivo was no greater than the transit time of [14C]sucrose. The binding of [3H]albumin to isolated microvessels in vitro was low, less than [3H]inulin and was nonsaturable. In conclusion these studies do not support the albumin receptor model for the transport of albumin-bound ligands into tissues such as brain.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994489     DOI: 10.1152/ajpendo.1985.249.3.E264

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  20 in total

Review 1.  Endothelial vesicles in the blood-brain barrier: are they related to permeability?

Authors:  P A Stewart
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

Review 2.  The clinical use of albumin: the point of view of a specialist in intensive care.

Authors:  Pietro Caironi; Luciano Gattinoni
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

3.  Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin.

Authors:  Joseph A Falcone; Therese S Salameh; Xiang Yi; Benjamin J Cordy; William G Mortell; Alexander V Kabanov; William A Banks
Journal:  J Pharmacol Exp Ther       Date:  2014-07-15       Impact factor: 4.030

Review 4.  Blood-brain barrier structure and function and the challenges for CNS drug delivery.

Authors:  N Joan Abbott
Journal:  J Inherit Metab Dis       Date:  2013-04-23       Impact factor: 4.982

5.  Blood-brain barrier transport of cationized immunoglobulin G: enhanced delivery compared to native protein.

Authors:  D Triguero; J B Buciak; J Yang; W M Pardridge
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Plasma binding and transport of diazepam across the blood-brain barrier. No evidence for in vivo enhanced dissociation.

Authors:  R K Dubey; C B McAllister; M Inoue; G R Wilkinson
Journal:  J Clin Invest       Date:  1989-10       Impact factor: 14.808

7.  Selective availability of protein bound estrogen and estrogen conjugates to the rat kidney.

Authors:  G Chaudhuri; C Verheugen; W M Pardridge; H L Judd
Journal:  J Endocrinol Invest       Date:  1987-06       Impact factor: 4.256

8.  Macromolecular permeability across the blood-nerve and blood-brain barriers.

Authors:  J F Poduslo; G L Curran; C T Berg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

9.  Nanoparticle-based evaluation of blood-brain barrier leakage during the foreign body response.

Authors:  Andrew J Sawyer; Themis R Kyriakides
Journal:  J Neural Eng       Date:  2013-01-21       Impact factor: 5.379

Review 10.  Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy.

Authors:  Zhibo Liu; Xiaoyuan Chen
Journal:  Chem Soc Rev       Date:  2016-03-07       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.